Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery-Reference-Cited by-同舟云学术

Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery

Published:2019-04-03 Issue:6 Volume:5 Page:1013-1021
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Torelli Nicholas J.¹,Akhtar Afroza¹,DeFrees Kyle²,Jaishankar Priyadarshini²,Pemberton Orville A.¹,Zhang Xiujun¹,Johnson Cody¹,Renslo Adam R.²^ORCID,Chen Yu¹^ORCID

Affiliation:

1. Department of Molecular Medicine, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd, MDC 3522, Tampa, Florida 33612, United States

2. Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California San Francisco, 600 16th Street, Genentech Hall N572B, San Francisco, California 94158, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.9b00052

Reference81 articles.

1. Crystal Structures of Penicillin-Binding Protein 6 from Escherichia coli

2. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine.

3. The Crystal Structure of Phosphonate-Inhibited d-Ala-d-Ala Peptidase Reveals an Analogue of a Tetrahedral Transition State,